
Conference Coverage
about 2 hours ago
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PVabout 19 hours ago
New TROP2-Targeted ADC Shows Promise in TNBC: Erika Hamilton, MDabout 19 hours ago
Targeted Therapies, Key Subgroup Insights to Watch at ASH 2025Latest Content

Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss

52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV

Innovative Approaches in Academic Neurology Workflows

Quality Improvement Program Dramatically Boosts Sleep Apnea Testing After Stroke in VA Hospitals

5 Things Driving Better Dental Health Access in Underserved Communities

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Hereditary ovarian cancer genes occur across diverse populations, supporting inclusive genetic testing.

Minimally invasive thymectomy for ocular myasthenia gravis (MG) enhanced complete stable remission rates and reduced surgical risks.

Experts met in Park City, Utah, on October 7, 2025, to discuss how new technologies can help address chronic kidney disease.

A phase 3 trial shows lumateperone added to antidepressant therapy delivers greater symptom improvement and maintains a favorable safety profile in adults with MDD.

ACIP delayed the vote on the hepatitis B vaccine schedule amid ongoing controversy and misinformation surrounding vaccine safety and infant immunization.

Patients with stage I to IIIA NSCLC had lower 2- and 4-year mortality in states that expanded Medicaid coverage.

As open enrollment continues, 77% of surveyed Americans were happy with their options for 2026 health care coverage, although cost concerns surfaced.

Polarized dermatoscopes produced higher-quality teledermatology images but at greater cost, raising questions about feasibility and equitable access.



























































